GlassScriptPhysician profile
Jon-Michael Allen
NPI 1477976892
$1,209.34
in general payments reported to CMS, 2019-2025
13 companies · $332 in 2025
The $332 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $32.61 · 2023: $322 · 2024: $523 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,176.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $457.32 | 2023-2025 | |
| Pfizer INC. | $170.82 | 2023-2024 | |
| Glaxosmithkline, LLC. | $134.94 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $69.13 | 2023-2024 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $64.29 | 2024-2025 | Ozempic, Rybelsus |
| Takeda Pharmaceuticals U.S.A., INC. | $61.56 | 2023-2024 | Trintellix, Gattex |
| Exact Sciences Corporation | $56.45 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lundbeck LLC | $50.08 | 2024 | Rexulti |
| Amgen INC. | $43.11 | 2024-2025 | Otezla, Repatha, Evenity |
| Zimmer Biomet Holdings, INC. | $32.61 | 2022 | |
| Lilly USA, LLC | $25.05 | 2025 | Mounjaro, Zepbound |
| Otsuka America Pharmaceutical, INC. | $23.52 | 2025 | Rexulti |
| Ibsa Pharma INC. | $20.46 | 2024 | Flector, Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon-Michael Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.